Abstract
Rheumatoid arthritis (RA) is a common chronic autoimmune joint disease characteristic of elevated proliferation and infiltration of fibroblast-like synoviocytes (FLS). Here, we aimed to explore the mechanisms of the Tanshinone IIA (Tan IIA)-induced apoptosis of FLS from patients with RA (termed RAFLS). Cell Counting Kit-8 (CCK-8) assay and Annexin V staining revealed that RAFLS viability decreased and apoptosis increased after Tan IIA treatment. Long non-coding RNA (lncRNA) GAS5 expression was significantly decreased in the synovial tissues and RAFLS, while Tan IIA treatment resulted in an up-regulation of GAS5. Consistently, knockdown of GAS5 using siRNA inhibited RAFLS apoptosis. Mechanistically, GAS5 knockdown down-regulated the expression of cleaved caspase-3 and caspase-9 in the RAFLS cells and activated the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway. These data indicate that Tan IIA promotes RAFLS apoptosis by up-regulating lncRNA GAS5, with enhanced expression of cleaved caspase-3/caspase-9 and inhibited PI3K/AKT signaling.
References
May 12, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Adam MorMichael H Pillinger
May 26, 2007·Nature Reviews. Immunology·Iain B McInnes, Georg Schett
Nov 14, 2012·Nature Reviews. Rheumatology·Nunzio Bottini, Gary S Firestein
Jun 13, 2014·Biological & Pharmaceutical Bulletin·Ligang JieWeifeng Sun
Jul 20, 2014·Journal of Ethnopharmacology·Francesco MaioneNicola Mascolo
Oct 12, 2014·Cancer Letters·Radha MunagalaRamesh C Gupta
Apr 14, 2015·Pharmaceutical Biology·Huilin HuGuanmin Tang
Oct 28, 2016·Arthritis & Rheumatology·Mark J Pearson, Simon W Jones
May 28, 2016·Current Drug Targets·Qin Ma, Jian-Guo Jiang
Sep 20, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qiang LiLi-Xia Liu
Oct 16, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dong XueXiaozhou He
Dec 28, 2016·International Journal of Molecular Medicine·Fang PanChunpeng Pei
Jan 25, 2017·Journal of Biochemical and Molecular Toxicology·Yandan WangJunpeng Luo
May 26, 2017·Clinical and Experimental Immunology·S ZhangA Xu
Jun 15, 2017·Lancet·Iain B McInnes, Georg Schett
Sep 26, 2017·PloS One·Lei ChenWusong Tong
Oct 20, 2017·Journal of Cellular and Molecular Medicine·Jie LiYu-Fei Liu
Dec 19, 2017·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Che-Yi LinChuan-Hang Yu
Feb 8, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yang Wang, Daliang Kong
Citations
Mar 19, 2020·Chinese Medical Journal·Min-Xi Lao, Han-Shi Xu
Jun 6, 2020·Frontiers in Pharmacology·Hongyan DuLigang Jie
Jun 23, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Hening ChenLimin Chai
Oct 3, 2020·Bioengineering & Translational Medicine·Louis J BornSteven M Jay
Dec 5, 2019·Biomolecules·Qing ZhangChunjie Wu
Aug 28, 2019·Journal of Cellular Biochemistry·Ruhai YiYueqing Su
Oct 13, 2019·Rheumatology·Yilong FangWei Wei
Oct 3, 2020·Bioscience Reports·Anfang CuiWei Yu
Nov 21, 2020·Autoimmunity·Zhou YangYu-Wei Zhan
Dec 16, 2020·Journal of Clinical Laboratory Analysis·Weiwei LiuXiaodan Mo
Oct 23, 2020·Journal of Orthopaedic Surgery and Research·Yin GuanYue Wang
Feb 28, 2021·Genes & Genomics·Sabrina Ka Man Tam, Danny Chi Yeu Leung
Feb 22, 2021·Molecular and Cellular Biochemistry·Tao PengYankai Jiang
Mar 6, 2021·Frontiers in Immunology·Xinpeng ZhouDongyi He
Aug 4, 2020·Journal of Translational Autoimmunity·Yaoyao Zou, Hanshi Xu
Mar 30, 2021·Frontiers in Pharmacology·Chenggui MiaoJinling Huang
Apr 19, 2019·Journal of Translational Internal Medicine·Junyu LiangJin Lin
Feb 24, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Miao-Juan ShiHui Zhang